Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07006896 · ClinicalTrials.gov registry record · NA
Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin
A NA study of Cesarean Delivery and Labor Induction, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07006896: Recruiting NA study of Cesarean Delivery and Labor Induction, sponsored by University of Pennsylvania.
NCT07006896 is a NA study of Cesarean Delivery and Labor Induction that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 100 participants, below the 3,473-participant average among 10 other Cesarean Delivery trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07006896, a NA study of Cesarean Delivery and Labor Induction, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized trial of patients undergoing a term (≥37 weeks) induction of labor with a history of one prior Cesarean delivery, wherein the provider intends to use a Foley catheter for cervical ripening. The investigators will be comparing Foley alone with concurrent Foley and Oxytocin use at the start of the induction. With this trial, the investigators aim to test our central hypothesis that concurrent Foley and Oxytocin will decrease time to delivery without increasing risks, compared to Foley alone.
Primary Outcome
The primary endpoint will be time from start of induction until delivery (hours)
Conditions Studied
Interventions
- DRUG Oxytocin
- DEVICE Foley balloon
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-07-10 |
| Est. Completion | 2027-05-01 |
| Phase | NA |
What NCT07006896 shows while recruiting
NCT07006896 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,473-participant average among 10 other Cesarean Delivery trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Cesarean Delivery appearing as the primary indexed condition, and to 2 interventions - of which Oxytocin is the first listed.
NCT07006896 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07006896 about?
NCT07006896 is a clinical study titled "Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin". A randomized trial of patients undergoing a term (≥37 weeks) induction of labor with a history of one prior Cesarean delivery, wherein the provider intends to use a Foley catheter for cervical ripening. The investigators will be comparing Foley alone with concurrent Foley and Oxytocin use at the sta...
What is the current status of trial NCT07006896?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-07-10. Estimated completion is 2027-05-01.
What conditions does trial NCT07006896 study?
This clinical trial studies the following conditions: Cesarean Delivery, Labor Induction.
What interventions are being tested in trial NCT07006896?
The interventions under investigation include: Oxytocin (DRUG), Foley balloon (DEVICE).
Who is sponsoring clinical trial NCT07006896?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07006896 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cesarean Delivery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07006896's enrollment target sits among peer trials
100 9th of 10 higher than 2 of 10 other Cesarean Delivery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cesarean Delivery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post-Operative Cesarean Section Cosmesis
RECRUITING · NA
-
IC-CS Risk: Patient Outcomes
ACTIVE NOT RECRUITING · NA
-
Delayed Cord Clamping at Term Cesarean
COMPLETED · NA
-
COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block
RECRUITING · Phase 4
-
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
RECRUITING
-
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI